Understanding genetic risk of preterm birth in British South Asian women

  • Research institute:

    Institute for Women’s Health,
    University College London

  • Project dates:

    Grant Awarded: 28 Jun 2024

  • Funding awarded:

    Grant Amount: £50,000

South Asian women have a higher chance of preterm birth, but we don’t understand why. In this project Dr Julia Zöllner is investigating whether variations in DNA might partly explain this elevated risk. This research could lead to new ways to help predict if someone is at risk of preterm labour, allowing doctors to intervene early to prevent their baby from being born too soon.

The challenge

Most women give birth prematurely without any warning, and we still don’t know why this is the case. South Asian women in particular have a higher risk of preterm birth compared to white European women, but the reasons for this are unclear.

We need to better understand the different factors that put women at risk of preterm birth, so that doctors can intervene early to prevent babies from being born too soon.

The project

Variations in our DNA can affect our chances of developing many different diseases and conditions. And there is increasing evidence that variations in a woman’s DNA may affect her risk of preterm birth. South Asian women are at increased risk of preterm birth, and Dr Julia Zöllner believes that their genetic heritage could partly explain this elevated risk.

In this project, Dr Zöllner is using data from an existing study called the Genes and Health cohort, which includes genetic information from thousands of British South Asian people. By analysing this data using cutting-edge techniques, she is looking for variations in the DNA that might affect a person’s chances of having a preterm baby before 36 weeks – which carries the highest risk to the baby.

What difference will this project make?

We need to better understand what puts different people at risk of going into labour early. The knowledge generated by Dr Zöllner’s research could eventually lead to genetic tests for the British South Asian community to predict a person’s chances of preterm birth. It could also improve our understanding of the genetic causes of preterm birth for all groups of women. Ultimately, Dr Zollner’s research could help to predict and prevent preterm labour, and ensure more babies are born healthy.

Borne logo
This research project is fully funded and supported exclusively by Borne.

Discover other projects

Lunenfeld-Tanenbaum Research Institute, Toronto, Canada

Testing the long-term health impact of a new drug to prevent preterm birth

Prof Stephen Lye and colleagues have identified a drug which can prevent preterm birth in animal studies. In this project, the team are investigating whether the drug improves the long-term health of newborns. The evidence generated promises to enable the team to test the drug in human clinical trials. If successful, this may one day provide a new option to prevent some babies from being born too soon.omega-3 fatty acids in the blood. The evidence generated could change global food and health policy, preventing preterm births and improving the health of mothers and babies worldwide.

Chelsea & Westminster Hospital, London

The FAB study – testing an omega-3 oil supplement to prevent preterm birth

Previous research has suggested that omega-3 fatty acids may prevent preterm birth, but clinical trials of supplements have had mixed results. The FAB study is testing the benefits of a particular supplement in a group of women in India with low levels of omega-3 fatty acids in the blood. The evidence generated could change global food and health policy, preventing preterm births and improving the health of mothers and babies worldwide.

Imperial College London

Investigating how immune cells help the placenta to implant correctly

Dr Viki Male and her team have found that immune cells called uNK1 cells may play a key role in helping the placenta implant into the womb correctly. In this project, Dr Male is studying tiny protein-filled packages inside uNK1 cells, to understand exactly how they might support placental implantation.